Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Recall Number: D-1467-2019
Firm: American Health Packaging
Classification: Class II
Status: Terminated
Report Date: 20190717
Initiation Date: 20190509
Termination Date: 20200909
Reason for Recall
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Product Description
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories